systemic-onset juvenile idiopathic arthritis

January 17, 2020January 17, 2020

Long-term Use of Biologic Therapies for sJIA Are Safe, Study Finds

News

Long-term use of biologic therapies in people with systemic-onset juvenile idiopathic arthritis (sJIA) is acceptably safe, with varying rates of infections and macrophage activation syndrome depending on choice of medication, ... Read more

October 4, 2019October 4, 2019

Differences Seen in Gut Bacteria of Children with Systemic-Onset JIA, Study Says

News

Children with systemic-onset juvenile idiopathic arthritis have significant differences in the composition of gut bacteria compared to healthy children, which may be partially resolved by treatments that stop disease activity, ... Read more

February 27, 2019February 27, 2019

Tacrolimus May be Effective Therapeutic Option for Children With SOJIA, Small Study Says

News

Tacrolimus, an investigational immunosuppressive treatment, may be an effective therapeutic option for children and adolescents with systemic-onset juvenile idiopathic arthritis (SOJIA), a study says. The study, “Treatment of patients with ... Read more